Abstract
BackgroundThe tuberculin skin test (TST) is still the standard test for detecting latent infection by M tuberculosis (LTBI). Given that the Brazilian Health Ministry recommends that the treatment of latent tuberculosis (LTBI) should be guided by the TST results, the present study sets out to describe the coverage of administering the TST in people living with HIV at two referral health centers in the city of Recife, where TST is offered to all patients. In addition, factors associated with the non-application of the test and with positive TST results were also analyzed.MethodsA cross-sectional study was carried out with HIV patients, aged 18 years or over, attending outpatient clinics at the Correia Picanço Hospital/SES/PE and the Oswaldo Cruz/UPE University Hospital, who had been recommended to take the TST, in the period between November 2007 and February 2010. Univariate and multivariate logistic regression analyses were carried out to establish associations between the dependent variable - taking the TST (yes/no), at a first stage analysis, and the independent variables, followed by a second stage analysis considering a positive TST as the dependent variable. The odds ratio was calculated as the measure of association and the confidence interval (CI) at 95% as the measure of accuracy of the estimate.ResultsOf the 2,290 patients recruited, 1087 (47.5%) took the TST. Of the 1,087 patients who took the tuberculin skin test, the prevalence of TST ≥ 5 mm was 21.6% among patients with CD4 ≥ 200 and 9.49% among those with CD4 < 200 (p = 0.002). The patients most likely not to take the test were: men, people aged under 39 years, people with low educational levels and crack users. The risk for not taking the TST was statiscally different for health service. Patients who presented better immunity (CD4 ≥ 200) were more than two and a half times more likely to test positive that those with higher levels of immunodeficiency (CD4 < 200).ConclusionsConsidering that the TST is recommended by the Brazilian health authorities, coverage for taking the test was very low. The most serious implication of this is that LTBI treatment was not carried out for the unidentified TST-positive patients, who may consequently go on to develop TB and eventually die.
Highlights
The tuberculin skin test (TST) is still the standard test for detecting latent infection by M tuberculosis (LTBI)
In countries with a low prevalence of TB/HIV co-infection the use of HAART is associated with a marked reduction in the incidence of many opportunistic infections [10,14,15,16], while in countries with a high prevalence of co-infection it is still unclear whether this protective effect occurs [17]
Given that the Brazilian Health Ministry recommends that LTBI treatment should be guided by the results of the TST [42,43,44] the present study aims to describe the coverage of administrating the TST in people living with HIV/ AIDS, attended at two health centers in the city of Recife, where TST is available
Summary
The tuberculin skin test (TST) is still the standard test for detecting latent infection by M tuberculosis (LTBI). The HIV epidemic has had serious consequences around the world and especially in developing countries. Tuberculosis is still the leading cause of death in HIV positive patients in various parts of the world, especially in countries where the disease is rife and resources are limited [7,8,9]. In countries with a low prevalence of TB/HIV co-infection the use of HAART is associated with a marked reduction in the incidence of many opportunistic infections [10,14,15,16], while in countries with a high prevalence of co-infection it is still unclear whether this protective effect occurs [17]. To establish a substantial impact on the incidence of TB, it would be necessary to begin HAART early in the course of HIV infection, with a high level of coverage and adherence [18]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.